Dec. 11 2023
Source Page: SACN vitamin D and health reportFound: Stolzenberg -Solomon et al. (2010) reported a significant increase in pancreatic cancer risk associated
Mentions:
1: Nigel Evans (Con - Ribble Valley) read the First time; to be read a Second time on Friday 23 February 2024, and to be printed (Bill 72).Cancer - Speech Link
A Bill to require the Secretary of State to lay before Parliament an annual report on the allocation of research funding into cancers with the lowest survival rates in the UK, including lung, liver, brain, pancreatic cancer, and certain childhood cancers, including an assessment of the options for increasing funding for research with the aim of increasing survival rates for those cancers; and for connected purposes.
Dec. 06 2023
Source Page: NHS recovery plan: progress report 2023Found: If a cancer patient breaches cancer waiting times standards it is crucial that the journey is analysed
Mentions:
1: Lord Markham (Con - Life peer) made against cancer. - Speech Link
2: Lord Markham (Con - Life peer) We absolutely need to bear down on cancer wait times. - Speech Link
3: Baroness Armstrong of Hill Top (Lab - Life peer) Among those that it is now seeing for the cancer pathway, only 2% actually end up having cancer. - Speech Link
4: Lord Turnberg (Lab - Life peer) with pancreatic cancer and colon cancer. - Speech Link
5: Lord Markham (Con - Life peer) The noble Lord is absolutely correct that, while we have made good progress in many areas, pancreatic - Speech Link
Asked by: Kerry McCarthy (Labour - Bristol East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of (a) NHS treatment standards and (b) the adequacy of survival rates for people diagnosed with pancreatic cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Standards for service delivery covering both benign and malignant disease is set out in the
NHS England’s Hepato-Pancreatic Biliary (HPB) service specification.
With support and input from HPB cancer clinical experts and patient and public voice representatives, including Pancreatic Cancer UK, the service specification has recently been revised to reflect current care pathways and update references to national policy, guidance and guidelines, including guidance from the National Institute for Health and Care Excellence. The revised specification is expected to be in use across the National Health Service in England by April 2024.
Although no specific assessment has currently been made on the adequacy of the survival rates for people diagnosed with pancreatic cancer, the Government is committed to diagnosing 75% of stageable cancers at stage 1 & 2 by 2028. This threshold is key to improving outcomes and survival rates, including for people diagnosed with pancreatic cancer.
Asked by: Gulhane, Sandesh (Scottish Conservative and Unionist Party - Glasgow)
Question
To ask the Scottish Government whether it will provide an update on whether funding for the hepatocellular carcinoma and pancreatic pathway pilot project will be extended for 12 months to March 2025, in order to overcome reported initial delays in the roll-out and to provide a mature source of data and patient experience to demonstrate how liver and pancreatic pathways can be improved.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
The Scottish Government awarded the Scottish HepatoPancreatoBiliary Network funding of £653,000 over two years to redesign the pancreatic and liver cancer pathways.
This pilot is the first of its kind across the UK. It aims to provide a nationally more efficient, standardised patient-centred pathway for people with pancreatic and liver cancers, with earlier diagnosis, referral and management decisions following a Realistic Medicine approach.
The funding comes to an end in March 2024 and an evaluation of the pilot’s achievements against these aims will be completed to inform decisions about future funding.
In the meantime, work continues to establish Rapid Cancer Diagnostic Services (RCDS) across NHS Scotland – interim evaluation shows that hepato-pancreato-biliary cancer is one of the most common cancers being diagnosed through the new fast-track diagnostic pathways. There are currently five RCDSs in Scotland.
Written Evidence Nov. 29 2023
Inquiry: Men's healthFound: Blood Cancer 26.3 48.6 1.85 Brain Tumours 7.9 11.6 1.47 Breast Cancer 40.0 0.5 0.01 Cervical
Nov. 28 2023
Source Page: Clinical Impact Awards 2022: personal statementsFound: National Clinical Impact award: N1 < Personal statement 1) I set up 3D -Laparoscopic liver & pancreatic
Asked by: Choudhury, Foysol (Scottish Labour - Lothian)
Question
To ask the Scottish Government, in light of the launch of Pancreatic Cancer UK’s report, Faster. Fairer. Funded., what assessment it has made of the merits of implementing an optimal care pathway for pancreatic cancer.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
The Scottish Government awarded the Scottish HepatoPancreatoBiliary Network funding of £653,000 over two years to redesign the pancreatic and liver cancer pathways. The Pathway Improvement Project is now live across all health boards.
This pilot is the first of its kind across the UK. It aims to provide a nationally more efficient, standardised patient centred pathway for cancer patients, with earlier diagnosis, referral and management decisions following a Realistic Medicine approach.
The funding comes to an end in March 2024 and an evaluation of the pilot’s achievements against these aims will be completed to inform decisions about future funding.
Through the Detect Cancer Earlier (DCE) Programme, the Centre for Sustainable Delivery (CfSD) continue to design and support the implementation of optimal cancer diagnostic pathways. As reflected in the Cancer Strategy, lung, head and neck and colorectal cancer have been identified as the first tranche, following an extensive evidence review with clinical experts. Once developed, this exercise will be repeated to determine the next optimal cancer pathways to be developed for NHS Scotland.
In the meantime, work continues to establish Rapid Cancer Diagnostic Services (RCDS) across NHS Scotland – interim evaluation shows that HPB is one of the most common cancers being diagnosed through the new fast-track diagnostic pathways. There are currently five RCDSs in Scotland.